ライフサイエンスコーパス: cardiopulmonary

1 Ultimately, these cardiopulmonary abnormalities resulted in impaired oxyge

2 nal outcome or quality of life measures, and cardiopulmonary adverse events were rarely reported.

3 ation systems: the Cardiohelp system (Maquet Cardiopulmonary AG), the Dideco ECC.O5 (Sorin Group), an

4 lonic activity (22.7% vs 4.2%; P < .001) and cardiopulmonary arrest (9.7% vs 0.5%, P < .001) vs patie

5 nd neurological outcomes following pediatric cardiopulmonary arrest (CPA).

6 ic therapy during pulmonary embolism-induced cardiopulmonary arrest and discuss the role of thromboly

7 er, n = 11), including advance warning of 27 cardiopulmonary arrest events (26%) for which return of

8 f monitored patients, without an increase in cardiopulmonary arrest events.

9 and treatment of cardiovascular collapse or cardiopulmonary arrest in an adult or pediatric patient

10 ith those of patients who did not experience cardiopulmonary arrest using propensity score matching w

11 Compared with sepsis survivors without cardiopulmonary arrest, sepsis survivors who received ca

12 The composite endpoint of cardiopulmonary arrest, unplanned ICU admission, or deat

13 Cardiopulmonary arrests and in-hospital mortality were a

14 cation outcomes, total telemetry census, and cardiopulmonary arrests in comparison with the previous

15 The number of cardiopulmonary arrests was 126 in the 13 months preinte

16 on to conventional surgery (0.6%) and use of cardiopulmonary bypass (0.7%) were rare.

17 ed before, during and after deep hypothermic cardiopulmonary bypass (CPB) in nine neonates.

18 Cardiopulmonary bypass (CPB) provokes inflammation culmi

19 ciated with cerebral hypoxia-ischemia during cardiopulmonary bypass (CPB) remains limited, largely du

20 performing CABG both off-pump (OPCAB) and on cardiopulmonary bypass (CPB).

21 cardiopulmonary bypass (on pump) or without cardiopulmonary bypass (off pump).

22 (CABG) surgery may be performed either with cardiopulmonary bypass (on pump) or without cardiopulmon

23 ion of haptoglobin at end and 24 hours after cardiopulmonary bypass (R = 0.12 and 0.15, respectively)

24 tively), lactate dehydrogenase levels at end cardiopulmonary bypass (R = 0.27), and change in creatin

25 T1 correlated with RV T1 (r=0.45, P<0.001), cardiopulmonary bypass (r=0.30, P=0.007), and aortic cro

26 inotropes, and RBC transfusion starting from cardiopulmonary bypass and ending 8 hours after arrival

27 ed for nonemergent cardiac surgery requiring cardiopulmonary bypass and had recognized risk factors f

28 Generation of plasma hemoglobin during cardiopulmonary bypass and male gender are associated wi

29 uggested that CABG techniques that eliminate cardiopulmonary bypass and reduce aortic manipulation ma

30 Levels of plasma hemoglobin increased during cardiopulmonary bypass and were associated (p < 0.01) wi

31 ive patients undergoing cardiac surgery with cardiopulmonary bypass at 12 hospitals from October 6, 2

32 n, the hepatic resection was performed under cardiopulmonary bypass because of extended vena cava thr

33 y bypass and were associated (p < 0.01) with cardiopulmonary bypass duration (R = 0.22), depletion of

34 rposition approach to liver transplantation, cardiopulmonary bypass during liver transplantation in t

35 tween ages 1 month to 18 years who underwent cardiopulmonary bypass for cardiac surgery and survived

36 ey injury in infants and children undergoing cardiopulmonary bypass for cardiac surgery.

37 acic surgery and a possible association with cardiopulmonary bypass heater-cooler units following ale

38 onary bypass, and 2 hours and 24 hours after cardiopulmonary bypass in 60 subjects.

39 l improvements, including the development of cardiopulmonary bypass in the 1950s, large-scale repair

40 Cardiopulmonary bypass initiates a systemic inflammatory

41 sed sterile water for heater-cooler units of cardiopulmonary bypass machines.

42 In addition, the elimination of cardiopulmonary bypass may reduce the risk of short-term

43 ement of patients requiring procedures using cardiopulmonary bypass or interventions in the catheteri

44 near horizon is the combination of advanced cardiopulmonary bypass plus a cocktail of multiple agent

45 -associated lipocalin measured 3 hours after cardiopulmonary bypass provided excellent early risk str

46 a cardiovascular surgeon, perfusionist, and cardiopulmonary bypass pump facilitates lifesaving repai

47 ia-induced cardiac arrest followed by 30 min cardiopulmonary bypass resuscitation.

48 or acute insulin resistance associated with cardiopulmonary bypass surgery.

49 ood operation (HR, 2.3; P=0.001), and longer cardiopulmonary bypass time (HR, 1.1 per 10 minutes; P=0

50 prised 72% of procedures and had a mean (SD) cardiopulmonary bypass time of 200 minutes (83) minutes.

51 In the CABG group, cardiopulmonary bypass time or days in intensive care di

52 Cardiopulmonary bypass time was the only independent sur

53 r resistance index, graft ischemic time, and cardiopulmonary bypass time, donor low-dose dopamine was

54 included pre-operative diuretic use, longer cardiopulmonary bypass time, operation prior to 1991, at

55 h the presentation, blood loss, and need for cardiopulmonary bypass to facilitate repair.

56 patients had a moderate or large injury, and cardiopulmonary bypass was required in 13 patients with

57 ombined coronary artery bypass grafting with cardiopulmonary bypass were enrolled from June 2013 unti

58 cheduled for routine cardiac procedures with cardiopulmonary bypass without documented dementia were

59 c subgroups of pediatric patients undergoing cardiopulmonary bypass would benefit from potential trea

60 s between intervention (ie, after removal of cardiopulmonary bypass) and closure of chest.

61 line (in a subset), the beginning and end of cardiopulmonary bypass, and 2 hours and 24 hours after c

62 ure, avoidance of the detrimental effects of cardiopulmonary bypass, and larger effective orifice are

63 re of injury, type of repair, utilization of cardiopulmonary bypass, and outcome.

64 Conventional MV surgery requires cardiopulmonary bypass, aortic cross-clamping, cardiople

65 and repair on an arrested heart, but require cardiopulmonary bypass, aortic cross-clamping, sternotom

66 ergoing coronary artery bypass grafting with cardiopulmonary bypass, levosimendan compared with place

67 less than 18 years old, procedures requiring cardiopulmonary bypass, no preexisting renal dysfunction

68 ts who underwent elective cardiac surgery on cardiopulmonary bypass, paired samples of the right atri

69 Under cardiopulmonary bypass, the papillary muscle tips in 6 s

70 igations were pursued: (1) identification of cardiopulmonary bypass-associated M. chimaera infection

71 Eighteen probable cases of cardiopulmonary bypass-associated M. chimaera infection

72 patients who underwent cardiac surgery with cardiopulmonary bypass.

73 e undergoing cardiac surgery with the use of cardiopulmonary bypass.

74 hours, and 18-24 hours after separation from cardiopulmonary bypass.

75 nction in patients after cardiac surgery and cardiopulmonary bypass.

76 ples before and after the ischemic insult of cardiopulmonary bypass.

77 e undergoing cardiac surgery with the use of cardiopulmonary bypass.

78 Cardiopulmonary complications are the leading cause of m

79 Gastrointestinal, infectious, and cardiopulmonary complications of care were the most comm

80 Gastrointestinal, infectious, and cardiopulmonary complications of care were the most comm

81 DMD is characterized by musculoskeletal and cardiopulmonary complications, resulting in shorter life

82 patients seem to benefit because of reduced cardiopulmonary complications.

83 eal membrane oxygenation therapy to mitigate cardiopulmonary compromise in patients with glyphosate-s

84 e safety of ECA use in patients with serious cardiopulmonary conditions, patients with intracardiac s

85 Cardiopulmonary costs accounted for 23% of resting EE, b

86 Cardiopulmonary, demographic, and anthropometric assessm

87 IC, promoting proper left-right patterning, cardiopulmonary development and renal morphogenesis.

88 Particulate matter exposure and cardiopulmonary differences in the Multi-Ethnic Study of

89 exposure may be associated with subclinical cardiopulmonary differences in this general population s

90 sociated with increased morbidity across the cardiopulmonary disease spectrum.

91 els adjusted for age, race, body mass index, cardiopulmonary disease, alcohol use, pacemaker, cholest

92 ffects, including premature mortality due to cardiopulmonary diseases and lung cancer.

93 exclusively associated with prematurity and cardiopulmonary diseases in industrialized countries, pr

94 conditions, including vitamin A deficiency, cardiopulmonary diseases, and hypoxia.

95 Hypoxia is often associated with cardiopulmonary diseases, which represent some of the le

96 c heart disease, and those free from chronic cardiopulmonary diseases.

97 Pulmonary arterial hypertension (PAH) is a cardiopulmonary disorder characterized by increased bloo

98 monary arterial hypertension (PAH) is a rare cardiopulmonary disorder that affects children and adult

99 ng in the reduction or mitigation of adverse cardiopulmonary distress associated with nanopharmaceuti

100 arance of nanoparticles in mediating adverse cardiopulmonary distress in pigs irrespective of complem

101 metry from a spherical shape (which triggers cardiopulmonary distress) to either rod- or disk-shape m

102 We recorded cardiopulmonary dynamics in supine syncope patients and

103 to traffic pollution prevents the beneficial cardiopulmonary effects of walking in people with COPD,

104 h continuous distending pressure had adverse cardiopulmonary effects.

105 ars or older, underwent: 6-minute walk test (cardiopulmonary endurance), chair stands in 30 seconds (

106 Data from a cardiopulmonary exercise (CPX) test are used to determin

107 chocardiography at rest and immediately post-cardiopulmonary exercise test in 207 patients (63 +/- 8

108 Heart rate recovery after a maximal cardiopulmonary exercise test was used as a surrogate fo

109 healthy controls performed a maximal graded cardiopulmonary exercise test with continuous measuremen

110 undergone a Fontan procedure and subsequent cardiopulmonary exercise test.

111 Unlike adult patients, the utility of cardiopulmonary exercise testing (CPET) in children as a

112 Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides a thoro

113 In the past several decades, cardiopulmonary exercise testing (CPX) has seen an expon

114 All subjects underwent cardiopulmonary exercise testing and cardiac magnetic re

115 Patients underwent cardiopulmonary exercise testing and echocardiography to

116 e was peak oxygen consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 2

117 Conventional cardiopulmonary exercise testing can objectively measure

118 data at rest and during maximal incremental cardiopulmonary exercise testing from 87 consecutive hea

119 MR-augmented cardiopulmonary exercise testing is feasible in both hea

120 Cardiopulmonary exercise testing is feasible in children

121 developed magnetic resonance (MR)-augmented cardiopulmonary exercise testing to achieve this goal an

122 n=18), and control subjects (n=30) underwent cardiopulmonary exercise testing with invasive hemodynam

123 We performed maximum incremental cardiopulmonary exercise testing with invasive hemodynam

124 We performed cardiopulmonary exercise testing with invasive monitorin

125 Echocardiography, cardiopulmonary exercise testing, and laboratory evaluat

126 atched for age, height, and weight underwent cardiopulmonary exercise testing, echocardiography inclu

127 ization, including serum biomarker analysis, cardiopulmonary exercise testing, echocardiography, and

128 then had pre-randomisation assessments with cardiopulmonary exercise testing, symptom questionnaires

129 surgical patients, heart rate recovery after cardiopulmonary exercise testing, time/frequency measure

130 s with HF who underwent clinically indicated cardiopulmonary exercise testing.

131 P = 0.005) but no relations with cardiopulmonary exercise testing.

132 logy of Fallot (n=10) underwent MR-augmented cardiopulmonary exercise testing.

133 ise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 c

134 A patient with cardiopulmonary failure after glyphosate-surfactant into

135 the occurrence of its 2 major complications: cardiopulmonary failure and encephalomalacia.

136 vides support for patients with severe acute cardiopulmonary failure, allowing the application of lun

137 atory support for patients with severe acute cardiopulmonary failure.

138 ne oxygenation was applied within 4 hours of cardiopulmonary failure.

139 ficantly associated with less improvement in cardiopulmonary fitness (VO2peak; beta=-0.165, P<0.001),

140 Greater cardiopulmonary fitness in young adulthood, less decline

141 le cell trait (SCT) to racial disparities in cardiopulmonary fitness is not known, despite concerns t

142 ibrosis of heart and lungs, GTx-026 returned cardiopulmonary function and intensity of fibrosis to he

143 Mental status, cardiopulmonary function.

144 play an important role in regulating various cardiopulmonary functions, maintaining homeostasis under

145 assess the clinical significance of measured cardiopulmonary hemodynamics in hypertrophic cardiomyopa

146 Cardiopulmonary human and rat tissues from PAH patients

147 on on flow is necessary for diagnostics; (c) cardiopulmonary imaging, where cardiovascular flow, func

148 vehicle-treated castrated mdx mice exhibited cardiopulmonary impairment and fibrosis of heart and lun

149 cutis laxa, dysmorphic facial features, and cardiopulmonary involvement identified biallelic missens

150 r pulmonary endarterectomy (PEA) by means of cardiopulmonary magnetic resonance (MR) imaging.

151 ality, functional measures, quality of life, cardiopulmonary morbidity (e.g., hypotension, bradycardi

152 erplexing possibility that the PM2.5 C-R for cardiopulmonary mortality and some other major endpoints

153 near: approximately 25%) of the total annual cardiopulmonary mortality attributable to PM2.5.

154 he largest U.S. environmental health risk is cardiopulmonary mortality from ambient PM2.5.

155 Cardiopulmonary organ dysfunction and chronic kidney inj

156 complications secondary to anesthesia), and cardiopulmonary outcomes (ie, hypotension, myocardial in

157 ding PEGylated nanoparticles, induce adverse cardiopulmonary reactions in sensitive human subjects, a

158 patient deaths and approximately 190 severe cardiopulmonary reactions occurring in close temporal re

159 rds model for each city, adjusting for prior cardiopulmonary-related hospitalizations and year, and s

160 exogenous peptide can reduce the severity of cardiopulmonary remodeling and function in PAH in rats.

161 The effect of ELA treatment on cardiopulmonary remodeling in PAH was investigated in th

162 , the reason for cardiac arrest to assist in cardiopulmonary resuscitation (1B-2C depending on rhythm

163 th myoclonus had longer time to professional cardiopulmonary resuscitation (8.6 vs 7.0 min; p < 0.001

164 ta on the prevalence or outcome of bystander cardiopulmonary resuscitation (BCPR) in children 18 year

165 1 million units, and control extracorporeal cardiopulmonary resuscitation (c-ECPR), which did not re

166 The quality of cardiopulmonary resuscitation (CPR) affects hemodynamics

167 t is associated with low survival, but early cardiopulmonary resuscitation (CPR) and defibrillation c

168 he American Heart Association guidelines for cardiopulmonary resuscitation (CPR) and emergency cardio

169 To describe temporal trends in bystander cardiopulmonary resuscitation (CPR) and first-responder

170 alized children in the United States receive cardiopulmonary resuscitation (CPR) annually.

171 Bystander-initiated cardiopulmonary resuscitation (CPR) increases patient su

172 On the basis of laboratory cardiopulmonary resuscitation (CPR) investigations and l

173 induction of therapeutic hypothermia during cardiopulmonary resuscitation (CPR) may improve neurolog

174 nalyzed risks according to whether bystander cardiopulmonary resuscitation (CPR) or defibrillation wa

175 Cardiopulmonary resuscitation (CPR) performed by bystand

176 Bystander cardiopulmonary resuscitation (CPR) significantly improv

177 Cardiopulmonary resuscitation (CPR) training in high sch

178 Cardiopulmonary resuscitation (CPR) training rates in th

179 the potential to help maintain high-quality cardiopulmonary resuscitation (CPR), but despite their i

180 hree million people in Sweden are trained in cardiopulmonary resuscitation (CPR).

181 enhances oxygenation and circulation during cardiopulmonary resuscitation (CPR).

182 Conversations about goals of care and cardiopulmonary resuscitation (CPR)/intubation for patie

183 Although extracorporeal cardiopulmonary resuscitation (E-CPR) can result in surv

184 Survival trends after in-hospital cardiopulmonary resuscitation (ICPR) for cardiac arrest

185 ent protocols: sodium nitroprusside-enhanced cardiopulmonary resuscitation (n=8), sodium nitroprussid

186 n=73/112) and 74.6% in patients who required cardiopulmonary resuscitation (n=91/122).

187 to two experimental groups: t-extracorporeal cardiopulmonary resuscitation (t-ECPR) group, which rece

188 County-level rates of bystander cardiopulmonary resuscitation and automated external def

189 Additional adjustment of bystander cardiopulmonary resuscitation and automated external def

190 ghborhoods had the lowest rates of bystander cardiopulmonary resuscitation and automatic external def

191 he association between bystander treatments (cardiopulmonary resuscitation and automatic external def

192 are group received a standard pamphlet about cardiopulmonary resuscitation and cardiopulmonary resusc

193 n from the MRI suite, before the delivery of cardiopulmonary resuscitation and defibrillation, potent

194 Importance: The 2015 cardiopulmonary resuscitation and emergency cardiovascul

195 life support and 1 pediatric Consensuses on Cardiopulmonary Resuscitation and Emergency Cardiovascul

196 annual series of International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascul

197 ican Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascul

198 A video depicting cardiopulmonary resuscitation and explaining resuscitati

199 ompare female and male rescuers in regard to cardiopulmonary resuscitation and leadership performance

200 During phase 1, quality of cardiopulmonary resuscitation and patient outcomes were

201 e been significant improvements in bystander cardiopulmonary resuscitation and survival outcome for o

202 Significant variation in rates of bystander cardiopulmonary resuscitation and survival were observed

203 n cardiac arrest is poor despite advances in cardiopulmonary resuscitation and the use of therapeutic

204 ha-Syn mice were subjected to cardiac arrest/cardiopulmonary resuscitation and treated with either a

205 dication for ECMO after a cardiac procedure, cardiopulmonary resuscitation before ECMO placement, and

206 were metastatic disease (odds ratio, 1.99), cardiopulmonary resuscitation before ICU admission (odds

207 pital mortality were age (odds ratio, 1.02), cardiopulmonary resuscitation before ICU admission (odds

208 cerebral oxygenation greater than 50% during cardiopulmonary resuscitation best predicted cerebral pe

209 ral oxygenation during the last 5 minutes of cardiopulmonary resuscitation best predicted the return

210 ma following experimental cardiac arrest and cardiopulmonary resuscitation by exerting its effect via

211 th increased mortality during extracorporeal cardiopulmonary resuscitation compared with normoxia (od

212 Distribution of cardiopulmonary resuscitation duration differed by outco

213 For cardiopulmonary resuscitation duration up to 37.0 minute

214 In particular, measurement of cardiopulmonary resuscitation elements and neurological

215 The relative incidence of cardiopulmonary resuscitation events was higher for card

216 onstrates that sodium nitroprusside-enhanced cardiopulmonary resuscitation facilitates intra-cardiopu

217 Animals received manual cardiopulmonary resuscitation for 10 minutes before the

218 on cardiac arrest followed by extracorporeal cardiopulmonary resuscitation for 6 hours.

219 0,078 children enrolled, 139 (1.4%) received cardiopulmonary resuscitation for more than or equal to

220 st, age 18 years old or older, and prolonged cardiopulmonary resuscitation greater than or equal to 5

221 itation in the sodium nitroprusside-enhanced cardiopulmonary resuscitation group (83+/-15 mL/min vs 2

222 Influence of cardiopulmonary resuscitation guidelines on nationwide s

223 he impact of 2010 American Heart Association cardiopulmonary resuscitation guidelines on survival.

224 ant change in survival before and after 2010 cardiopulmonary resuscitation guidelines.

225 nge in survival trends before and after 2010 cardiopulmonary resuscitation guidelines.

226 monary arrest, sepsis survivors who received cardiopulmonary resuscitation had a greater risk of all-

227 diopulmonary resuscitation facilitates intra-cardiopulmonary resuscitation hypothermia.

228 ygenation was deployed during extracorporeal cardiopulmonary resuscitation in 31 patients (21% of the

229 arrest in 53.8%, 51.1%, and 52.1%; bystander cardiopulmonary resuscitation in 44.7%, 30.3%, and 23.4%

230 rdiac dysfunction in 3,005 patients (66.5%), cardiopulmonary resuscitation in 877 patients (19.4%), a

231 or impedance threshold device with standard cardiopulmonary resuscitation in out-of-hospital cardiac

232 ogy death (CED) immediately after successful cardiopulmonary resuscitation in patients without ST-seg

233 tubation in the last 30 days of life, and no cardiopulmonary resuscitation in the last 30 days of lif

234 Carotid blood flow was higher during cardiopulmonary resuscitation in the sodium nitroprussid

235 ruption at 24 hours following cardiac arrest/cardiopulmonary resuscitation in wild-type mice but not

236 O in elderly patients and patients requiring cardiopulmonary resuscitation indicates that less invasi

237 Mdivi-1 administration during cardiopulmonary resuscitation inhibited dynamin-related

238 than 35 degrees C beginning from the time of cardiopulmonary resuscitation initiation.

239 Cardiopulmonary resuscitation is a lifesaving technique

240 Higher cerebral oxygenation during cardiopulmonary resuscitation is associated with return

241 ventricular dilatation on ultrasound during cardiopulmonary resuscitation is particularly associated

242 ary embolism and use of thrombolytics during cardiopulmonary resuscitation may need to be more routin

243 partially be explained by fewer unsolicited cardiopulmonary resuscitation measures and inferior fema

244 e in different domains and fewer unsolicited cardiopulmonary resuscitation measures compared with mal

245 iated with improved knowledge of in-hospital cardiopulmonary resuscitation options and cardiopulmonar

246 ge of patients with OHCA receiving bystander cardiopulmonary resuscitation or a lay automatic externa

247 resuscitation and measured durations of all cardiopulmonary resuscitation pauses.

248 ences, with female rescuers showing inferior cardiopulmonary resuscitation performance, which can par

249 itation (n=8), sodium nitroprusside-enhanced cardiopulmonary resuscitation plus epinephrine (n=10), a

250 he control and sodium nitroprusside-enhanced cardiopulmonary resuscitation plus epinephrine groups, r

251 hlet about cardiopulmonary resuscitation and cardiopulmonary resuscitation preference options plus ro

252 tions summary articles that will include the cardiopulmonary resuscitation science reviewed by the In

253 on has initiated a near-continuous review of cardiopulmonary resuscitation science that replaces the

254 e addition of thrombolytic to extracorporeal cardiopulmonary resuscitation significantly improved car

255 (n = 3,207) of sepsis patients who received cardiopulmonary resuscitation survived to discharge.

256 al cardiopulmonary resuscitation options and cardiopulmonary resuscitation terminology among patients

257 survivors of sepsis who received in-hospital cardiopulmonary resuscitation than in those who did not,

258 Specifically, greater than or equal to 60% cardiopulmonary resuscitation time with regional cerebra

259 ance of survival during the first minutes of cardiopulmonary resuscitation to enable prompt orientati

260 d to hospital discharge after 1-3 minutes of cardiopulmonary resuscitation versus 28% (9/32) after mo

261 Shorter duration of cardiopulmonary resuscitation was associated with higher

262 Extracorporeal cardiopulmonary resuscitation was not independently asso

263 -year postdischarge survival rates following cardiopulmonary resuscitation were 28%, 23%, and 14%, re

264 utcomes of ICU sepsis survivors who received cardiopulmonary resuscitation were compared with those o

265 sk factors for long-term mortality following cardiopulmonary resuscitation were male sex, older age,

266 thm, witnessed cardiac arrest, and bystander cardiopulmonary resuscitation were more likely to surviv

267 ry OH VF/VT cardiac arrest requiring ongoing cardiopulmonary resuscitation were transported by emerge

268 n alpha-Syn mice subjected to cardiac arrest/cardiopulmonary resuscitation, 7.5% hypertonic saline tr

269 rity of illness scores, higher prevalence of cardiopulmonary resuscitation, and greater resource util

270 heart beat, weanability from extracorporeal cardiopulmonary resuscitation, and left ventricular syst

271 ected to 4-minute cardiac arrest followed by cardiopulmonary resuscitation, and randomized either to

272 s, cardiac arrest characteristics, bystander cardiopulmonary resuscitation, automated external defibr

273 Cardiac arrest is potentially reversible by cardiopulmonary resuscitation, defibrillation, cardiover

274 1.79 (95% CI, 1.17-2.76); and (5) bystander cardiopulmonary resuscitation, HR, 1.38 (95% CI, 1.02-1.

275 These data establish that contemporary PICU cardiopulmonary resuscitation, including long durations

276 , age, witnessed status, attempted bystander cardiopulmonary resuscitation, location of arrest, chest

277 efined as PE- or bleeding-related mortality, cardiopulmonary resuscitation, or intensive care unit ad

278 lity were age, severity of illness, previous cardiopulmonary resuscitation, previous ICU admission, m

279 y resuscitation, including long durations of cardiopulmonary resuscitation, results in high rates of

280 objective of this study was to determine if cardiopulmonary resuscitation-targeted to arterial blood

281 en and were less likely to receive bystander cardiopulmonary resuscitation.

282 rsus 89% (8/9) after more than 30 minutes of cardiopulmonary resuscitation.

283 attempted after 30 minutes of extracorporeal cardiopulmonary resuscitation.

284 n wild-type mice subjected to cardiac arrest/cardiopulmonary resuscitation.

285 asive cerebral oxygenation monitoring during cardiopulmonary resuscitation.

286 determined at 24 hours after cardiac arrest/cardiopulmonary resuscitation.

287 vival rate and neurocognitive recovery after cardiopulmonary resuscitation.

288 est and discuss the role of thrombolytics in cardiopulmonary resuscitation.

289 st five minutes of emergency medical service cardiopulmonary resuscitation.

290 lation, a witnessed arrest, or had bystander cardiopulmonary resuscitation.

291 eceived surface cooling at the initiation of cardiopulmonary resuscitation.

292 e ICU, compared with receiving a pamphlet on cardiopulmonary resuscitation.

293 ypeople and healthcare providers who perform cardiopulmonary resuscitation.

294 for cardiogenic shock, and 3) extracorporeal cardiopulmonary resuscitation.

295 n for respiratory failure and extracorporeal cardiopulmonary resuscitation.

296 xygenation, and 412 underwent extracorporeal cardiopulmonary resuscitation.

297 Following experimental cardiac arrest/cardiopulmonary resuscitation: 1) continuous hypertonic

298 thrombolytic therapy was administered during cardiopulmonary resuscitative efforts.

299 ELA expression was reduced in cardiopulmonary tissues from PAH patients and PAH rat mo

300 udies that ignored the contribution of HR to cardiopulmonary work.